-
G342013-10mgGuanfacine is an activator of α2A-AR.
-
G342013-250mgGuanfacine is an activator of α2A-AR.
-
G342013-25mgGuanfacine is an activator of α2A-AR.
-
G342013-50mgGuanfacine is an activator of α2A-AR.
-
H339238-500mgHydroxyzine is an H1 receptor antagonist. It is also an anxiolytic and antihistaminic.
-
G118963-1mgHyperglycemic-glycogenolytic factor.
-
G118963-5mgHyperglycemic-glycogenolytic factor.
-
P127143-10mgIbrutinib is a potent and highly selective Brutons tyrosine kinase (Btk) inhibitor with IC50 of 0.5 nM, modestly potent to Bmx, CSK, FGR, BRK, HCK, less potent to EGFR, Yes, ErbB2, JAK3, etc.
-
P127143-1gIbrutinib is a potent and highly selective Brutons tyrosine kinase (Btk) inhibitor with IC50 of 0.5 nM, modestly potent to Bmx, CSK, FGR, BRK, HCK, less potent to EGFR, Yes, ErbB2, JAK3, etc.
-
P127143-250mgIbrutinib is a potent and highly selective Brutons tyrosine kinase (Btk) inhibitor with IC50 of 0.5 nM, modestly potent to Bmx, CSK, FGR, BRK, HCK, less potent to EGFR, Yes, ErbB2, JAK3, etc.
-
P127143-25gIbrutinib is a potent and highly selective Brutons tyrosine kinase (Btk) inhibitor with IC50 of 0.5 nM, modestly potent to Bmx, CSK, FGR, BRK, HCK, less potent to EGFR, Yes, ErbB2, JAK3, etc.
-
P127143-50mgIbrutinib is a potent and highly selective Brutons tyrosine kinase (Btk) inhibitor with IC50 of 0.5 nM, modestly potent to Bmx, CSK, FGR, BRK, HCK, less potent to EGFR, Yes, ErbB2, JAK3, etc.